Data / Form D filings / Akari Therapeutics Plc
Akari Therapeutics Plc: Form D filings
Akari Therapeutics Plc, a health care company in Tampa, FL, filed 14 Form D notices with the SEC between 2012 and 2026. The latest, on June 3, 2026, reports $1.8 million sold of a $5.5 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 EAST JACKSON STREET SUITE 3300, Tampa, FL, 33602
- Phone
- (929) 274-7510
- Industry
- Other Health Care
- Entity type
- Other
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1541157
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | New notice | $5,500,000 | $1,833,333 | $3,666,667 | 6 | May 20, 2026 | sec.gov |
| Oct 24, 2025 | New notice | $6,250,000 | $6,250,000 | 4 | Oct 16, 2025 | sec.gov | |
| Jan 9, 2024 | New notice | $2,000,001 | $2,000,001 | 2 | Dec 27, 2023 | sec.gov | |
| Oct 19, 2023 | New notice | $1,971,001 | $1,971,001 | 11 | Oct 4, 2023 | sec.gov | |
| Sep 27, 2022 | New notice | $12,835,000 | $12,835,000 | 21 | Sep 14, 2022 | sec.gov | |
| Jul 22, 2021 | New notice | $12,318,688 | $12,318,688 | 62 | Jul 7, 2021 | sec.gov | |
| Mar 11, 2020 | New notice | $9,554,528 | $9,554,528 | 53 | Feb 13, 2020 | sec.gov | |
| Jul 12, 2019 | New notice | $4,499,945 | $4,499,945 | 45 | Jun 28, 2019 | sec.gov | |
| Sep 28, 2015 | New notice | $75,000,000 | $75,000,000 | 28 | Sep 18, 2015 | sec.gov | |
| Sep 30, 2013 | New notice | $12,516,232 | $12,516,232 | 18 | Sep 24, 2013 | sec.gov | |
| Feb 1, 2013 | New notice | $10,000,000 | $931,000 | $9,069,000 | 7 | Jan 18, 2013 | sec.gov |
| Dec 13, 2012 | Amendment | $1,503,000 | $1,503,000 | 20 | Nov 30, 2012 | sec.gov | |
| Dec 12, 2012 | New notice | $1,503,000 | $1,503,000 | 20 | Nov 30, 2012 | sec.gov | |
| Apr 13, 2012 | New notice | $1,100,000 | $0 | $1,100,000 | 2 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Abizer Gaslightwala | Executive Officer, Director | President and Chief Executive Officer |
| Kameel Farag | Executive Officer | Interim Chief Financial Officer |
| Rob Bazemore | Director | |
| Hoyoung Huh | Director | |
| Jim Neal | Director | |
| Ray Prudo | Director | |
| Samir Patel | Director | |
| Sandip Patel | Director |
Other health care companies in Florida that filed recently
- Lev 18, Inc. $250,000 · Oct 9, 2026
- Coast Medical Innovations, LLC $550,000 · Oct 8, 2026
- Metabolica, Inc. offering · Oct 7, 2026
- Colonial Outpatient Surgery Center, LLC $915,156 · Sep 30, 2026
- VIRGO CAPITAL PARTNERS, LLC offering · Sep 17, 2026
- Prosper Health, Inc. $10 million · Sep 10, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in Florida · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Akari Therapeutics Plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.